SCHEMBL347214

SCHEMBL347214

COc1cc(OC)c(C(=O)O)cc1OC

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.73
FYN P06241 1/20 0.73
CYP3A4 P08684 1/20 0.63
KDM4E B2RXH2 8/20 0.62
ALDH1A1 P00352 4/20 0.62
HPGD P15428 3/20 0.62
KMT2A Q03164 3/20 0.55
HSD17B10 Q99714 2/20 0.55
MYC P01106 1/20 0.55
NPSR1 Q6W5P4 2/20 0.54
MEN1 O00255 2/20 0.53
HTT P42858 1/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
CA7 P43166 1/20 0.52
TPMT P51580 1/20 0.52
CA9 Q16790 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29765241 1.00 LCK (0.73) LCKFYNCYP3A4KDM4EALDH1A1
Hydrochloric Acid SCHEMBL22129893 0.98 LCK (0.70) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL2830233 0.95 LCK (0.72) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL8855393 0.94 LCK (0.66) LCKFYNCYP3A4KDM4EALDH1A1
Hydrochloric Acid SCHEMBL8902783 0.93 LCK (0.69) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL12444067 0.93 ALDH1A1 (0.64) LCKFYNCYP3A4KDM4EALDH1A1
Hydrochloric Acid SCHEMBL28599506 0.91 ALDH1A1 (0.62) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL30415497 0.90 LCK (0.72) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL1417516 0.90 LCK (0.72) LCKFYNCYP3A4KDM4EALDH1A1
SCHEMBL15680262 0.86 LCK (0.61) LCKFYNCYP3A4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-111233468-B Preparation method of yttrium-stabilized zirconium powder for structural component 长裕控股集团股份有限公司 2023-09-15 CN claimed
CN-111204802-B Preparation method of black yttrium-stabilized zirconia powder 长裕控股集团股份有限公司 2023-07-28 CN claimed
CN-112500159-B Preparation method of high-toughness high-strength black zirconia ceramic material 长裕控股集团股份有限公司 2023-05-23 CN claimed
CN-112679209-B Preparation method of black zirconia ceramic material 长裕控股集团股份有限公司 2023-04-14 CN claimed
CN-115683789-A Fungus fluorescent staining solution with double background removal reagents and preparation method and application thereof 浙江工业大学 2023-02-03 CN claimed
CN-112661504-B Preparation method of zirconia dental material 长裕控股集团股份有限公司 2023-01-31 CN claimed
CN-115420579-A High-contrast fungus fluorescent staining solution and preparation method and application thereof 浙江工业大学 2022-12-02 CN claimed
CN-112679209-A Preparation method of black zirconia ceramic material 长裕控股集团有限公司 2021-04-20 CN claimed
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2005-01-20 US claimed
WO-2004088028-A1 BLEACHING COMPOSITION COMPRISING AN ALKOXYLATED BENZOIC ACID THE PROCTER & GAMBLE COMPANY (US) 2004-10-14 WO claimed
US-6803395-B2 POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY XEROX CORPORATION 2004-10-12 US claimed
US-20040192571-A1 Bleaching composition comprising an alkoxylated benzoic acid THE PROCTER & GAMBLE COMPANY 2004-09-30 US claimed
EP-1462564-A1 Bleaching composition comprising trimethoxy benzoic acid or a salt thereof THE PROCTER & GAMBLE COMPANY (US) 2004-09-29 EP claimed
US-20030137570-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-24 US claimed
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-17 US claimed
US-20030119940-A1 Ink composition with improved lightfastness XEROX CORPORATION 2003-06-26 US claimed
US-6569511-B1 Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating XEROX CORPORATION 2003-05-27 US claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes LRRFIP1, LRRC59, MMS19 LCK 4708/4885FYN 4073/4885CYP3A4 2957/4885
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes ITGA1, ITGB1, ITGB8 LCK 4773/4885FYN 4171/4885CYP3A4 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.